Annals of Clinical Biochemistry > Annals of Clinical Biochemistry Online First > 10.1258/acb.2008.008018

This Article Full Text (PDF) All Versions of this Article: acb.2008.008018v1 45/6/571    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hirowatari, Y. Articles by Miida, T. Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Original Article

Measurement of cholesterol concentrations of major serum lipoprotein classes in haemodialysis patients by anion-exchange chromatography

Yuji Hirowatari¹, Hiroshi Yoshida², Yuriko Fueki³, Masayuki Ito³, Yutaka Ogura¹, Nobuyuki Sakurai⁴ and Takashi Miida⁵

¹ Bioscience Division, Tosoh Corporation, Kanagawa, Japan; ² Department of Laboratory Medicine, Jikei University Kashiwa Hospital, Chiba, Japan; ³ Graduate School of Medical and Dental Sciences Medicine, Niigata University, Niigata, Japan; ⁴ Murakami Memorial Hospital, Niigata, Japan; ⁵ Department of Clinical Laboratory Medicine, Juntendo University Hospital, Tokyo, Japan

Corresponding author: Dr Yuji Hirowatari. Email: hirowata{at}tosoh.co.jp

Background: Increased triglyceride (TG)-rich lipoproteins and decreased HDL that are implicated in the progression of atherosclerotic vascular diseases, are present in serum samples of patients undergoing haemodialysis (HD) therapy. Therefore, it is important to measure serum TG-rich lipoprotein concentrations to prevent the diseases.

Methods: The cholesterol concentrations of lipoprotein classes in serum samples from the HD patients (n = 18) and healthy subjects (n = 18) were analysed by our recently developed method of high-performance liquid chromatography (HPLC), in which the lipoprotein classes were separated using an anion-exchange column, and the cholesterol concentrations of each of those were measured enzymatically using a post-column reaction. The ability of fractionated lipoprotein cholesterol determination by this HPLC method is mostly equivalent to the determination ability of an ultracentrifugation (UC).

Results: HDL, LDL, and TG-rich lipoproteins, i.e. IDL, VLDL and chylomicrons, were well separated in the chromatograms. HDL cholesterol concentrations in the HD patients were significantly lower than in the healthy subjects (P < 0.0001), and IDL cholesterol concentrations and VLDL cholesterol concentrations in the HD patients were significantly higher than in the healthy subjects (P < 0.05). Profiles of these measured lipoprotein values were consistent with the previously reported lipoprotein values, measured ultracentrifugally characteristic of HD patients.

Conclusion: These results suggest that the HPLC method may be sufficiently applied to the assessment of serum lipoprotein profile in HD patients in place of the other method including an UC.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?